Log In
Print
BCIQ
Print
Print this Print this
 

PredictMDx for Glioblastoma

Also known as: PredictMDx for Brain

  Manage Alerts
Collapse Summary General Information
Company MDxHealth S.A.
DescriptionAssay for determining the methylation status of the O-6-methylguanine DNA methyltransferase (MGMT) gene
Molecular Target O6-alkylguanine alkyltransferase (MGMT)
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentPivotal
Standard IndicationCancer, Diagnostic
Indication DetailsIdentify glioblastoma patients most likely to respond to therapy; Identify patients with glioblastoma multiforme (GBM) who are more likely to respond to treatment with temozolomide
Regulatory Designation

Partner

Teva Pharmaceutical Industries Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today